Acibadem Altunizade Hospital
Üsküdar/stanbul, İ̇stanbul 34662
0 studies enrolling now · 3 studies all time
What they study most
Advanced or Metastatic Breast Cancer, Breast Cancer, Breast Neoplasms, Neoplasm Metastasis
Studies at this site
- A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
- A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment — Running, not enrolling